FXYD5 and metastatic malignant neoplasm: However, dysadherin expression may need to be interpreted in conjunction with other factors such as E-cadherin status, another cell membrane protein associated with dysadherin whose dysfunction lead to progression of benign tumor to aggressive metastatic cancer [39].